134 related articles for article (PubMed ID: 11474132)
1. Factors secreted by human neuroblastoma mediated doxorubicin resistance by activating STAT3 and inhibiting apoptosis.
Rebbaa A; Chou PM; Mirkin BL
Mol Med; 2001 Jun; 7(6):393-400. PubMed ID: 11474132
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis.
Alas S; Bonavida B
Clin Cancer Res; 2003 Jan; 9(1):316-26. PubMed ID: 12538484
[TBL] [Abstract][Full Text] [Related]
3. Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway.
Ryu K; Susa M; Choy E; Yang C; Hornicek FJ; Mankin HJ; Duan Z
BMC Cancer; 2010 May; 10():187. PubMed ID: 20459702
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression.
Epling-Burnette PK; Liu JH; Catlett-Falcone R; Turkson J; Oshiro M; Kothapalli R; Li Y; Wang JM; Yang-Yen HF; Karras J; Jove R; Loughran TP
J Clin Invest; 2001 Feb; 107(3):351-62. PubMed ID: 11160159
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin-induced apoptosis in caspase-8-deficient neuroblastoma cells is mediated through direct action on mitochondria.
Rebbaa A; Chou PM; Emran M; Mirkin BL
Cancer Chemother Pharmacol; 2001 Dec; 48(6):423-8. PubMed ID: 11800021
[TBL] [Abstract][Full Text] [Related]
6. Role of STAT3 in ischemic preconditioning.
Hattori R; Maulik N; Otani H; Zhu L; Cordis G; Engelman RM; Siddiqui MA; Das DK
J Mol Cell Cardiol; 2001 Nov; 33(11):1929-36. PubMed ID: 11708838
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells.
Burke WM; Jin X; Lin HJ; Huang M; Liu R; Reynolds RK; Lin J
Oncogene; 2001 Nov; 20(55):7925-34. PubMed ID: 11753675
[TBL] [Abstract][Full Text] [Related]
8. P53 mediates ceramide-induced apoptosis in SKN-SH cells.
Kim SS; Chae HS; Bach JH; Lee MW; Kim KY; Lee WB; Jung YM; Bonventre JV; Suh YH
Oncogene; 2002 Mar; 21(13):2020-8. PubMed ID: 11960374
[TBL] [Abstract][Full Text] [Related]
9. Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells.
Real PJ; Sierra A; De Juan A; Segovia JC; Lopez-Vega JM; Fernandez-Luna JL
Oncogene; 2002 Oct; 21(50):7611-8. PubMed ID: 12400004
[TBL] [Abstract][Full Text] [Related]
10. STAT3, but not ERKs, mediates the IL-6-induced proliferation of renal cancer cells, ACHN and 769P.
Horiguchi A; Oya M; Marumo K; Murai M
Kidney Int; 2002 Mar; 61(3):926-38. PubMed ID: 11849447
[TBL] [Abstract][Full Text] [Related]
11. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells.
Catlett-Falcone R; Landowski TH; Oshiro MM; Turkson J; Levitzki A; Savino R; Ciliberto G; Moscinski L; Fernández-Luna JL; Nuñez G; Dalton WS; Jove R
Immunity; 1999 Jan; 10(1):105-15. PubMed ID: 10023775
[TBL] [Abstract][Full Text] [Related]
12. Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death.
Zamo A; Chiarle R; Piva R; Howes J; Fan Y; Chilosi M; Levy DE; Inghirami G
Oncogene; 2002 Feb; 21(7):1038-47. PubMed ID: 11850821
[TBL] [Abstract][Full Text] [Related]
13. Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non-Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs.
Alas S; Bonavida B
Cancer Res; 2001 Jul; 61(13):5137-44. PubMed ID: 11431352
[TBL] [Abstract][Full Text] [Related]
14. STAT3 mediates the survival signal in oncogenic ras-transfected intestinal epithelial cells.
Zushi S; Shinomura Y; Kiyohara T; Miyazaki Y; Kondo S; Sugimachi M; Higashimoto Y; Kanayama S; Matsuzawa Y
Int J Cancer; 1998 Oct; 78(3):326-30. PubMed ID: 9766567
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3.
Zhang T; Jiang B; Zou ST; Liu F; Hua D
World J Gastroenterol; 2015 Feb; 21(6):1804-13. PubMed ID: 25684945
[TBL] [Abstract][Full Text] [Related]
16. Genomic profiling of acquired resistance to apoptosis in cells derived from human atherosclerotic lesions: potential role of STATs, cyclinD1, BAD, and Bcl-XL.
Gagarin D; Yang Z; Butler J; Wimmer M; Du B; Cahan P; McCaffrey TA
J Mol Cell Cardiol; 2005 Sep; 39(3):453-65. PubMed ID: 16005468
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cells.
Pu YS; Hour TC; Chuang SE; Cheng AL; Lai MK; Kuo ML
Prostate; 2004 Jul; 60(2):120-9. PubMed ID: 15162378
[TBL] [Abstract][Full Text] [Related]
18. The phosphotidyl inositol 3-kinase/Akt signal pathway is involved in interleukin-6-mediated Mcl-1 upregulation and anti-apoptosis activity in basal cell carcinoma cells.
Jee SH; Chiu HC; Tsai TF; Tsai WL; Liao YH; Chu CY; Kuo ML
J Invest Dermatol; 2002 Nov; 119(5):1121-7. PubMed ID: 12445202
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of JAK kinase activity enhances Fas-mediated apoptosis but reduces cytotoxic activity of topoisomerase II inhibitors in U266 myeloma cells.
Oshiro MM; Landowski TH; Catlett-Falcone R; Hazlehurst LA; Huang M; Jove R; Dalton WS
Clin Cancer Res; 2001 Dec; 7(12):4262-71. PubMed ID: 11751528
[TBL] [Abstract][Full Text] [Related]
20. Antiapoptotic effect of endothelin-1 in rat cardiomyocytes in vitro.
Ogata Y; Takahashi M; Ueno S; Takeuchi K; Okada T; Mano H; Ookawara S; Ozawa K; Berk BC; Ikeda U; Shimada K; Kobayashi E
Hypertension; 2003 May; 41(5):1156-63. PubMed ID: 12668584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]